Metrikler
Yayın
6
Açık Erişim
3
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (6)
SCI-E, SSCI, AHCI (6)
SCI-E, SSCI, AHCI, ESCI (6)
Scopus (6)
TRDizin (1)
2024
20241. Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis
GÜVEN D. C., Stephen B., ŞAHİN T. K., ÇAKIR İ. Y., AKSOY S.
Laryngoscope
, cilt.134, sa.1, ss.7-17, 2024 (SCI-Expanded, Scopus)
2023
20232. Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia
AKTAŞ B. Y., ATA E. B., ÇEŞMECİ E., ÇAKIR İ. Y., Coşkunpınar M., TAHILLIOĞLU Y., et al.
Current Oncology
, cilt.30, sa.11, ss.9689-9700, 2023 (SCI-Expanded, Scopus)
2022
20223. The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy
GÜVEN D. C., ŞAHİN T. K., Erul E., ÇAKIR İ. Y., ÜÇGÜL E., YILDIRIM H. Ç., et al.
JOURNAL OF CLINICAL MEDICINE
, cilt.11, sa.15, 2022 (SCI-Expanded, Scopus)
2022
20224. The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials
GÜVEN D. C., Stephen B., ŞAHİN T. K., ÇAKIR İ. Y., Erul E., AKSOY S.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
, cilt.174, 2022 (SCI-Expanded, Scopus)
2022
20225. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study
GÜVEN D. C., YILDIRIM H. Ç., ERUL E., ŞAHİN T. K., ÇAKIR İ. Y., AKTEPE O. H., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded, Scopus, TRDizin)
2021
20216. The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme
GÜVEN D. C., AKSUN M. S., ÇAKIR İ. Y., KILIÇKAP S., KERTMEN N.
FUTURE ONCOLOGY
, cilt.17, ss.4405-4413, 2021 (SCI-Expanded, Scopus)